The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Balchem's Revenue for the
three
months ended in Mar. 2026 was $271 Mil. Balchem's average Accounts Receivable for the
three
months ended in Mar. 2026 was $149 Mil.
Hence, Balchem's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.82.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Balchem Receivables Turnover Related Terms
Balchem Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Balchem's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BCPC vs PRM, SXT, CBT: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Balchem's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balchem Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balchem's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Balchem's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balchem (BCPC) has a Receivables Turnover of 1.82 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Balchem and its competitors. According to the industry distribution chart, Balchem ranks #465 out of 1578 companies in the Chemicals industry, placing it in the top 29.5%.
Is Balchem's Receivables Turnover too high?
Balchem's current Receivables Turnover is 1.82. The Chemicals industry median Receivables Turnover is 5.56. Balchem's value of 1.82 is 67.2% below this industry median. Based on the distribution chart, Balchem ranks #465 out of 1578 companies in the Chemicals industry, which is above the industry midpoint. Overall, Balchem has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's Receivables Turnover compare to PRM and SXT?
According to the Chemicals industry distribution chart, Balchem ranks #465 out of 1578 companies for Receivables Turnover. This puts Balchem in the upper half of its industry. The industry median Receivables Turnover is 5.56. Balchem's value of 1.82 is 67.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.56, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balchem's current Receivables Turnover of 1.82 is 67.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Balchem and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balchem's current Receivables Turnover is 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $177.28, compared to a current price of $168.89 — trading 4.7% below its estimated fair value. The current Receivables Turnover is 1.82 and 67.2% below the Chemicals industry median of 5.56. Balchem's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Balchem (BCPC), the current Receivables Turnover is 1.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balchem (BCPC) Overvalued in 2026?
Based on GuruFocus' analysis, Balchem stock appears to be undervalued.
The current stock price of $168.89 is trading 4.7% below its estimated GF Value™ of $177.28.
GuruFocus considers Balchem to be Fairly Valued.
Key valuation signals for BCPC:
Receivables Turnover: 1.82
GF Value™: $177.28 vs. price of $168.89 (4.7% below fair value)
Industry Position: 67.2% below the Chemicals median (#465 of 1578)
No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score
Get the complete analysis for BCPC
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCPC has been successfully added to your 
